Dan M. Roden

Specialty: Pharmacogenomics

Location: Unknown

Tier: ELITE

H-Index: 106

Years Active: 0

Hospital Affiliations

• Vanderbilt University - Faculty

Key Publications

1. "Pharmacogenomics." - Lancet (2019)
2. "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update." - Clin Pharmacol Ther (2022)
3. "Phenome-Wide Association Studies." - JAMA (2022)
4. "Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls." - Genet Med (2021)
5. "Fulminant Myocarditis with Combination Immune Checkpoint Blockade." - N Engl J Med (2016)

Knowledge Graph Relationships

Dan M. Roden is a Pharmacogenomics specialist affiliated with Vanderbilt University. Authored 5 scholarly articles.